{"mainPropery":{"diseaseId":10529,"diseaseName":"Myofibrillar myopathy","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10529/myofibrillar-myopathy","synonyms":["Desminopathy (type)","Alpha Beta crystallinopathy (type)","Myotilinopathy (type)","Zaspopathy (type)","Filaminopathy (type)","Desmin storage myopathy (former name)","Desmin related myopathy (former name)","Protein surplus myopathy (former name)"],"synonyms-with-source":[{"name":"Desminopathy (type)"},{"name":"Alpha Beta crystallinopathy (type)"},{"name":"Myotilinopathy (type)"},{"name":"Zaspopathy (type)"},{"name":"Filaminopathy (type)"},{"name":"Desmin storage myopathy (former name)"},{"name":"Desmin related myopathy (former name)"},{"name":"Protein surplus myopathy (former name)"}],"identifiers":[{"identifierType":"OMIM","identifierId":"601419"},{"identifierType":"ORPHANET","identifierId":"593"},{"identifierType":"UMLS","identifierId":"C2678065"}]},"diseaseCategories":[],"organizations":[{"resourceID":567,"resourceName":"Cardiomyopathy Association","abbreviation":"","address1":"Chiltern Court","address2":"Asheridge Road","address3":"Unit 10","address4":"Chesham Buckinghamshire HP5 2PX","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"+44 01494 791 224","tty":"","tollFree":"","fax":"+44 1923 249 987","email":"contact@cardiomyopathy.org","url":"http://www.cardiomyopathy.org","freeText":""},{"resourceID":604,"resourceName":"Children's Cardiomyopathy Foundation","abbreviation":"","address1":"P.O. Box 547","address2":"","address3":"","address4":"","address5":"","city":"Tenafly","state":"NJ","zip":"07670 ","country":"United States","phone":"","tty":"","tollFree":"866-808-CURE (2873) ","fax":"201-227-7016","email":"info@childrenscardiomyopathy.org","url":"http://www.childrenscardiomyopathy.org/"},{"resourceID":935,"resourceName":"Muscular Dystrophy Association","abbreviation":"MDA","address1":"222 S Riverside Plaza","address2":"Suite 1500","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"60606","country":"United States","phone":"","tty":"","tollFree":"1-833-275-6321 (Helpline)","fax":"","email":"resourcecenter@mdausa.org","url":"https://www.mda.org","freeText":""},{"resourceID":3761,"resourceName":"Myofibrillar Myopathy Facebook Support Group","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"","url":"https://www.facebook.com/groups/880994568701030/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/601419' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=%22myofibrillar+myopathy%22%5BAll+Fields%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Myofibrillar myopathy. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/myofibrillar-myopathy' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Myofibrillar myopathy. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1008/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=593' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=mfm' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/MESH:C580316' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Myofibrillar myopathy. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Myofibrillar myopathy:<br />\r\n<a href='https://www.cmdir.org/' target='_blank'>Congenital Muscle Disease International Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":4212,"questionText":"What is myofibrillar myopathy?","answerText":"<strong><strong>Myofibrilar myopathy (MFM)</strong>&nbsp;</strong>is a&nbsp;<a href=\"https://medlineplus.gov/neuromusculardisorders.html\">neuromuscular disease</a>&nbsp;characterized by slowly progressive muscle weakness that can involve both proximal muscles (such as hips and shoulders) and distal muscles (those further away from the trunk). Some affected individuals also experience muscle stiffness, aching, or cramps. Other symptoms that can be associated with MFM include pain and tingling in the limbs (<a href=\"https://medlineplus.gov/ency/article/000593.htm\">peripheral neuropathy</a>) or an enlarged and weakened heart (<a href=\"https://medlineplus.gov/cardiomyopathy.html\">cardiomyopathy</a>).[3155] Most people with MFM begin to develop muscle weakness in mid-adulthood, but features of the disease can appear anytime between infancy and late adulthood.[3155][3156]&nbsp;<br />\r\n<br />\r\nMFM is caused by a&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">mutation </a>&nbsp;(change) in any of several&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">genes</a>, including&nbsp;<a href=\"https://ghr.nlm.nih.gov/gene/DES\"><em>DES</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/CRYAB\"><em>CRYAB</em></a><em>,&nbsp; </em> <a href=\"https://ghr.nlm.nih.gov/gene/MYOT\"> <em>MYOT</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/LDB3\"><em>LDB3</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/FLNC\"><em>FLNC</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/BAG3\"><em>BAG3</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/FHL1\"><em>FHL1</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/TTN\"><em>TTN</em></a><em>,&nbsp;</em>and<em>&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/DNAJB6\"><em>DNAJB6</em></a><em>.</em>[3155][13982]<em>&nbsp;</em>The signs and symptoms of MFM can vary depending on the genetic cause. For some people, the exact genetic cause may be unknown.[3155] The mode of inheritance of the disease depends on exactly which gene is changed. MFM can be diagnosed with a&nbsp;<a href=\"https://medlineplus.gov/ency/article/003924.htm\">muscle biopsy</a>&nbsp;or other studies of muscle function. The diagnosis can be confirmed with&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/testing/genetictesting\">genetic testing</a>.[3155] Treatment may include&nbsp;<a href=\"http://www.wcpt.org/what-is-physical-therapy\">physical therapy</a>&nbsp;and assistive devices such as a cane or wheelchair for those with advanced muscle weakness. Affected individuals who have cardiomyopathy or an abnormal heart rhythm (<a href=\"https://medlineplus.gov/arrhythmia.html\">arrhythmia</a>) may require a&nbsp;<a href=\"https://medlineplus.gov/ency/article/007369.htm\">pacemaker</a>&nbsp;or&nbsp;<a href=\"https://medlineplus.gov/ency/article/007370.htm\">implantable cardioverter defibrillator (ICD)</a>.[3155]&nbsp;","dateModified":"2017-10-24T00:00:00"},"basicQuestions":[{"questionId":4214,"questionText":"What are the signs and symptoms of myofibrillar myopathy?","answerText":"Myofibrillar myopathy (MFM) primarily affects skeletal muscles, which are muscles that the body uses for movement. In some cases, the heart (cardiac) muscle is also affected. The signs and symptoms of MFM vary among affected individuals, typically depending on the exact genetic cause of the disease. Most people with this disease begin to develop muscle weakness (myopathy) in mid-adulthood. However, features of this disease can appear anytime between infancy and late adulthood.[3155][3156]<br />\r\n<br />\r\nMuscle weakness most often begins in the hands and feet (distal muscles), but some people first experience weakness in the muscles near the center of the body (proximal muscles). Facial muscle weakness can rarely cause swallowing and speech difficulties. The muscle weakness is progressive, meaning that it tends to worsen over time.[3155]<br />\r\n<br />\r\nOther signs and symptoms of MFM can include an enlarged and weakened heart muscle (<a href=\"https://medlineplus.gov/cardiomyopathy.html\">cardiomyopathy</a>) or an abnormal heart rhythm (<a href=\"https://medlineplus.gov/arrhythmia.html\">arrhythmia</a>), muscle pain (<a href=\"https://medlineplus.gov/ency/article/003178.htm\">myalgia</a>), and loss of sensation and weakness in the limbs (<a href=\"https://medlineplus.gov/ency/article/000593.htm\">peripheral neuropathy</a>). For some people, as the disease progresses, the muscles of the lungs may also be affected, which can result in respiratory failure. Individuals with this disease may have skeletal problems including joint stiffness (<a href=\"https://medlineplus.gov/ency/article/003185.htm\">contractures</a>) and abnormal curvature of the spine (<a href=\"https://medlineplus.gov/scoliosis.html\">scoliosis</a>). Rarely, people with this disease develop clouding of the front surface of the eyes (<a href=\"https://medlineplus.gov/cataract.html\">cataracts</a>).[3156]","dateModified":"2017-10-24T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":3155,"authors":"Selcen D and Engel AG","articleTitle":"Myofibrillar Myopathy","bookWebsiteJournalTitle":"GeneReviews","date":"October 29, 2012","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1499/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3156,"authors":"","articleTitle":"Myofibrillar myopathy","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January 2011","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/myofibrillar-myopathy","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12316,"questionText":"What causes myofibrillar myopathy?","answerText":"Myofibrillar myopathy (MFM) is caused by a&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">mutation</a>&nbsp;(change) in any of several&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">genes</a>, including&nbsp;<a href=\"https://ghr.nlm.nih.gov/gene/DES\"><em>DES</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/CRYAB\"><em>CRYAB</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/MYOT\"><em>MYOT</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/LDB3\"><em>LDB3</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/FLNC\"><em>FLNC</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/BAG3\"><em>BAG3</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/FHL1\"><em>FHL1</em></a><em>,&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/TTN\"><em>TTN</em></a><em>,&nbsp;</em>and<em>&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/gene/DNAJB6\"><em>DNAJB6</em></a><em>.</em>[3155][13982]<em>&nbsp;</em>These genes are all responsible for providing instructions to our bodies to make proteins that help keep our muscles strong. Specifically, the muscles are divided into units called&nbsp;<a href=\"https://www.nature.com/scitable/topicpage/the-sliding-filament-theory-of-muscle-contraction-14567666\">sarcomeres</a>. The proteins that are made by these genes are responsible for linking the sarcomeres together so that they are strong enough to help our bodies move.[3156]<br />\r\n<br />\r\nWhen there is a mutation in one of the genes associated with MFM, the muscles are weakened because there is not enough of the linking protein to help make the muscles strong. This causes the symptoms associated with MFM. Because each gene associated with MFM provides instructions for a protein that performs a slightly different function in the muscle, the exact symptoms that are present in each affected individual depends on the exact gene that is changed.[3156] There are rare reports of other genes that may be associated with myofibrillar myopathy.[13982] In about 50% of people who have MFM, the exact genetic cause of the disease is not identified.[3155] This may be because there are other genes that cause MFM that have not yet been discovered.[13982]&nbsp;","dateModified":"2017-10-24T21:02:00","resourceClassificationName":"Cause","references":[{"referenceId":3155,"authors":"Selcen D and Engel AG","articleTitle":"Myofibrillar Myopathy","bookWebsiteJournalTitle":"GeneReviews","date":"October 29, 2012","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1499/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3156,"authors":"","articleTitle":"Myofibrillar myopathy","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January 2011","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/myofibrillar-myopathy","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13982,"authors":"Oliv√© M, Kley RA, and Goldfarb LG","articleTitle":"Myofibrillar myopathies: new developments","bookWebsiteJournalTitle":"Current Opinion in Neurology","date":"October 2013","volume":"(26)5","pages":"527-535","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127196/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12317,"questionText":"How is myofibrillar myopathy inherited?","answerText":"Myofibrillar myopathy (MFM) can be inherited in a number of different ways depending on the exact&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a>&nbsp;that is changed. Most cases of MFM are caused by changes in genes that are inherited in an&nbsp;<a href=\"https://medlineplus.gov/ency/article/002049.htm\">autosomal dominant</a>&nbsp;manner.[3155] This means that only one copy of a gene needs to be changed in order for a person to have signs and symptoms of the disease. We inherit one copy of each gene from our mother and the other one from our father.&nbsp;<br />\r\n<br />\r\nIn some cases, people with an autosomal dominant form of MFM are the first people in their family who are diagnosed with the disease. This may occur for two reasons. First, it may be that the person diagnosed with the disease is the only person in the family with a genetic change. This means that the genetic change is new (<a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">de novo</a>) in the affected individual and it was not inherited from either parent. In other cases, it may be that the parents of the affected individual also have MFM, but they have a form of the disease that is slowly progressing or has not yet been diagnosed. Therefore, if a person is diagnosed with MFM and the exact genetic cause is known, it is important that their parents also receive&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/testing/genetictesting\">genetic testing</a>&nbsp;to determine if one of them also has the disease.&nbsp;<br />\r\n<br />\r\nMFM can exhibit&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/inheritance/penetranceexpressivity\">reduced penetrance</a>&nbsp;and&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/inheritance/penetranceexpressivity\">variable expressivity</a>. Reduced penetrance means that some people who have genetic changes that cause MFM may not have signs or symptoms of the disease. However, these people can still pass on MFM to their children. Variable expressivity means that the exact symptoms of each person with MFM can differ, even within the same family. For example, some affected individuals may have both&nbsp;<a href=\"https://medlineplus.gov/cardiomyopathy.html\">cardiomyopathy</a>&nbsp;and muscle weakness, while others may just have one or the other.[3155]<br />\r\n<br />\r\nIf MFM is caused by a change in the&nbsp;<em><a href=\"https://ghr.nlm.nih.gov/gene/FHL1\" target=\"_blank\">FHL1</a>&nbsp;</em>gene, it is inherited in an&nbsp;<a href=\"https://medlineplus.gov/ency/article/002051.htm\">X-linked manner</a>.[3155] This means that the&nbsp;<em>FHL1</em>&nbsp;gene is located on the X chromosome. The X chromosome is one of the sex chromosomes. Each woman has two X chromosomes, and each man has one X chromosome and one Y chromosome. Because men have only one X chromosome, they only have one copy of the&nbsp;<em>FHL1</em>&nbsp;gene. If this gene has a mutation, they will have MFM. However, women who have changes in one copy of the&nbsp;<em>FHL1</em>&nbsp;gene are known as carriers of the disease. Most carriers do not have signs or symptoms of MFM because they have another working copy of&nbsp;<em>FHL1</em>.&nbsp;<br />\r\n<br />\r\nIf MFM is caused by a change in&nbsp;<em><a href=\"https://ghr.nlm.nih.gov/gene/CRYAB\" target=\"_blank\">CRYAB</a>,&nbsp;</em>it is inherited in an&nbsp;<a href=\"https://medlineplus.gov/ency/article/002052.htm\">autosomal recessive</a>&nbsp;manner.[3155] This means that both copies of the&nbsp;<em>CRYAB&nbsp;</em>gene must be changed in order to have symptoms of the disease. Men and women with a mutation in only one copy of the&nbsp;<em>CRYAB</em>&nbsp;gene are known as carriers, meaning they do not have signs or symptoms of the disease. When two carriers of a&nbsp;<em>CRYAB&nbsp;</em>mutation have children together, for each child there is a:<br />\r\n<ul>\r\n    <li>25% chance that the child will have MFM</li>\r\n    <li>50% chance that the child will be a carrier of MFM like the parents</li>\r\n    <li>25% chance that the child will have two working copies of&nbsp;<em>CRYAB</em>, so the child will not have MFM and will not be a carrier.</li>\r\n</ul>","dateModified":"2017-10-24T21:05:00","resourceClassificationName":"Inheritance","references":[{"referenceId":3155,"authors":"Selcen D and Engel AG","articleTitle":"Myofibrillar Myopathy","bookWebsiteJournalTitle":"GeneReviews","date":"October 29, 2012","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1499/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12318,"questionText":"How is myofibrillar myopathy diagnosed?","answerText":"Myofibrillar myopathy (MFM) is diagnosed when an individual has signs and symptoms consistent with the disease such as progressive muscle weakness with or without&nbsp;<a href=\"https://medlineplus.gov/cardiomyopathy.html\">cardiomyopathy</a>. A healthcare professional may want to perform laboratory tests to rule out other causes of progressive muscle weakness. These tests may include:[3155]&nbsp;<br />\r\n<ul>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003929.htm\">Electromyography</a>: a study measuring the response of muscles to an electrical stimulus</li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003924.htm\">Muscle biopsy</a>: a sample of the muscle is taken to determine how it looks under a microscope</li>\r\n    <li><a href=\"https://medlineplus.gov/ency/article/003503.htm\">Creatine kinase</a>&nbsp;test: a test of an enzyme that can provide information about the health of the muscles &nbsp;</li>\r\n</ul>\r\nIf myofibrillar myopathy is suspected,&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/testing/genetictesting\">genetic testing</a>&nbsp;of the genes associated with the disease can be used to confirm the diagnosis and provide more information about long-term outlook.[13983]&nbsp;","dateModified":"2017-10-24T21:08:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":3155,"authors":"Selcen D and Engel AG","articleTitle":"Myofibrillar Myopathy","bookWebsiteJournalTitle":"GeneReviews","date":"October 29, 2012","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1499/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13983,"authors":"Connolly AM","articleTitle":"Myopathy, Myofibrillar","bookWebsiteJournalTitle":"National Organization for Rare Disorders","date":"2010","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/myopathy-myofibrillar/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12319,"questionText":"How might myofibrillar myopathy be treated?","answerText":"The treatment of myofibrillar myopathy (MFM) depends on the signs and symptoms present in each person. People who have progressive muscles weakness may require&nbsp;<a href=\"http://www.wcpt.org/what-is-physical-therapy\">physical therapy</a>&nbsp;and assistive devices such as a cane or wheelchair. Individuals who have&nbsp;<a href=\"https://medlineplus.gov/cardiomyopathy.html\">cardiomyopathy</a>&nbsp;or&nbsp;<a href=\"https://medlineplus.gov/arrhythmia.html\">arrhythmia</a>&nbsp;may require a&nbsp;<a href=\"https://medlineplus.gov/ency/article/007369.htm\">pacemaker</a>&nbsp;or&nbsp;<a href=\"https://medlineplus.gov/ency/article/007370.htm\">implantable cardioverter defibrillator (ICD)</a>. In severe cases, people with MFM may have progressive heart disease that requires a&nbsp;<a href=\"https://medlineplus.gov/hearttransplantation.html\">heart transplant</a>.[3155] Surveillance of the heart, lungs, and muscles are recommended every year or as determined by a doctor.<br />\r\n<br />\r\nFor some affected individuals, the progressive muscle weakness may affect the ability of the muscles of the lungs to work properly, especially at night. This may require respiratory support such as a&nbsp;<a href=\"https://medlineplus.gov/ency/patientinstructions/000458.htm\">ventilator</a>&nbsp;to make sure affected individuals are breathing properly.[3155]","dateModified":"2017-10-24T21:11:00","resourceClassificationName":"Treatment","references":[{"referenceId":3155,"authors":"Selcen D and Engel AG","articleTitle":"Myofibrillar Myopathy","bookWebsiteJournalTitle":"GeneReviews","date":"October 29, 2012","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1499/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12320,"questionText":"What is the long-term outlook for people affected with myofibrillar myopathy?","answerText":"Myofibrillar myopathy (MFM) is a progressive muscle disease. This means that the muscle weakness and other symptoms associated with the disease tend to get worse as people get older. More information may be available about the long-term outlook for each specific genetic change that causes MFM. In general, MFM that first shows symptoms beginning in childhood is more severe than when the onset of symptoms is later in adulthood.&nbsp;<br />\r\n<br />\r\nBecause MFM shows&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/inheritance/penetranceexpressivity\">variable expressivity</a>, the exact signs and symptoms for each person cannot be predicted, including whether or not an affected individual will have heart problems or breathing problems.[3155] If the heart problems and breathing problems are managed, people with MFM are expected to have a normal life expectancy.[13984]","dateModified":"2017-10-24T21:13:00","resourceClassificationName":"Prognosis","references":[{"referenceId":3155,"authors":"Selcen D and Engel AG","articleTitle":"Myofibrillar Myopathy","bookWebsiteJournalTitle":"GeneReviews","date":"October 29, 2012","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1499/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13984,"authors":"Ozkaya O","articleTitle":"Myofibrillar myopathies","bookWebsiteJournalTitle":"Muscular Dystrophy UK","date":"June 2017","volume":"","pages":"","url":"http://www.musculardystrophyuk.org/app/uploads/2016/06/Myofibrillar-myopathy-Final.pdf","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":6254,"phenoTypeName":"Adult onset","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8991,"phenoTypeName":"Bradycardia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8976,"phenoTypeName":"Dilated cardiomyopathy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8970,"phenoTypeName":"Hypertrophic cardiomyopathy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10695,"phenoTypeName":"Respiratory insufficiency due to muscle weakness","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":3870,"phenoTypeName":"Restrictive cardiomyopathy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":3859,"phenoTypeName":"Third degree atrioventricular block","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":9377,"phenoTypeName":"Bulbar palsy","percentRanges":"-"},{"phenoTypeId":13409,"phenoTypeName":"Constipation","percentRanges":"-"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","percentRanges":"-"},{"phenoTypeId":5216,"phenoTypeName":"Distal muscle weakness","percentRanges":"-"},{"phenoTypeId":13576,"phenoTypeName":"EMG: myopathic abnormalities","percentRanges":"-"},{"phenoTypeId":2766,"phenoTypeName":"Facial palsy","percentRanges":"-"},{"phenoTypeId":13774,"phenoTypeName":"Hyporeflexia of lower limbs","percentRanges":"-"},{"phenoTypeId":5272,"phenoTypeName":"Late-onset proximal muscle weakness","percentRanges":"-"},{"phenoTypeId":10466,"phenoTypeName":"Neck muscle weakness","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Myofibrillar_myopathy"}